Sep 30
|
Buy These Top 5 Price-to-Sales Stocks for Better Investment Returns
|
Sep 30
|
15 Best Dividend Stocks for Lifelong Passive Income
|
Sep 30
|
Pipeline Moves: Pfizer scores in Phase II cancer cachexia trial
|
Sep 30
|
Pfizer Inc. (PFE) Acquires Seagen for $43 Billion, Strengthening Oncology Leadership
|
Sep 29
|
Here is What Jim Cramer Likes Pfizer Inc. (NYSE:PFE)
|
Sep 18
|
Weight loss drug pricing under fire with pills on the horizon
|
Sep 18
|
3 Magnificent Dividend Stocks With Yields Above 5% to Buy Now and Hold Forever
|
Sep 18
|
Pfizer Inc. (PFE): Among the Best Stocks to Buy for Passive Income
|
Sep 18
|
Pfizer and AstraZeneca debate: when “the greater good” matters
|
Sep 17
|
Novartis' Kisqali Lowers Risk of Breast Cancer Recurrence by 28%
|
Sep 17
|
Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call with Analysts
|
Sep 17
|
FDA OKs third dose for Pfizer and Moderna Covid-19 vaccines
|
Sep 17
|
Lilly Gets FDA Approval for Eczema Drug Ebglyss
|
Sep 16
|
Is Pfizer Stock Going to $36? 1 Wall Street Analyst Thinks So.
|
Sep 16
|
Pipeline Moves: Novo Nordisk’s liraglutide scores in Phase III paediatric trial
|
Sep 16
|
Midday movers: Intel, Pfizer rise; Apple falls
|
Sep 16
|
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
|
Sep 16
|
Stocks to Watch Monday: DJT, Apple, Pfizer, Intel
|
Sep 16
|
ESMO 2024: Pfizer’s cachexia drug provides meaningful weight gain
|
Sep 16
|
Pfizer Drug Treating Fatal Weight Loss in Cancer Patients Found Effective
|